Accelerator Award: Partnership Strengthens CP Research
The Cerebral Palsy Research Network announces a new research award opportunity called “Accelerator Awards” made possible through the network’s partnership with the Cerebral Palsy Alliance Research Foundation (CPARF). Accelerator awards are up to $25,000 and are meant to rapidly advance research in the network. These awards will be made to investigators in the CP Research Network who put forth new study proposals and registry analyses that enhance the generation of new knowledge for the care and treatment of people with CP. The award process will be managed by Dr. Kristie Bjornson, the network’s Scientific Director who has a long track record in research funded by the National Institutes of Health (NIH).
“We reviewed all the funding mechanisms available to CP focused investigators and established a process that will really streamline the timeline for decision making and investigator feedback,” said Dr. Bjornson. “This award mechanism is a significant milestone for the CP Research Network because it provides the necessary funding to leverage our CP Registries for large public grant applications to answer key questions developed by the community of persons with CP. It is intended to secure time and resources that might not otherwise be available.”
The Accelerator Awards extend additional benefits to sites and investigators that join the CP Research Network. The network offers professional development opportunities, collaborative research partnerships, participation in quality improvement initiatives, implementation of care pathways and powerful research infrastructure hosted at its Data Coordinating Center at the University of Pittsburgh. Nonmembers can learn how to join the network or partner with existing members from our webinar on this topic.
The CP Research Network began taking applications from its site investigators as of May 1, 2023. Grant applications may be submitted on a rolling basis and may be approved in as little four weeks. This rollout aligns well with our annual investigators’ meeting at Nemours/AI duPont earlier this month, where 50 people, including network site investigators, community members, an NIH program officer, and members of leading advocacy groups, gathered to advance study concepts being developed within the network.